Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Slides:



Advertisements
Similar presentations
The ACTIVE Investigators. N Engl J Med 2009 Apr 3 [Epub]
Advertisements

Fat or Low-fat? Anwar T. Merchant ScD, MPH, DMD Department of Epidemiology and Biostatistics.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Fixed-Dose Combination Strategy on Adherence.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Proposal to Incorporate Trial Data Into a Hybrid.
R1. 이정미 / prof. 이상열. INTRODUCTION Type 2 diabetes is a major risk factor for cardiovascular disease The presence of both type 2 diabetes and.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Atherothrombosis J Am Coll Cardiol. 2012;60(10):
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Glycated Hemoglobin Measurement and Prediction of.
Middle age self-report risk score predicts cognitive functioning and dementia in 20– 40 years  Eero Vuoksimaa, Juha O. Rinne, Noora Lindgren, Kauko Heikkilä,
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated.
Volume 1, Issue 1, Pages (June 2015)
From ESH 2016 | LB 3: Davide Agnoletti, MD
The SPRINT Research Group
Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J
Arch Intern Med. 2004;164(13): doi: /archinte Figure Legend:
Relation between Cardiovascular Disease Risk Markers and Brain Infarcts Detected by Magnetic Resonance Imaging in an Elderly Population  Ruta Nylander,
Copyright © 2011 American Medical Association. All rights reserved.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Economic evaluation of MRC/BHF Heart Protection Study
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
LDL Cholesterol Lowering with Evolocumab and Outcomes in Patients with Peripheral Artery Disease: Insights from the FOURIER Trial Marc P. Bonaca, Patrice.
DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS  Teemu Paajanen, Shadi Mahdiani, Marie.
Copyright © 2012 American Medical Association. All rights reserved.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Prevention of Alzheimer’s disease – is it possible?
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Dementia risk model validation in low and middle income countries
Volume 93, Issue 6, Pages (June 2018)
Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease  Connie M. Rhee, MD, MSc, Kamyar Kalantar-Zadeh, MD, MPH, PhD, Vanessa Ravel,
Volume 16, Issue 12, Pages (December 2017)
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Baseline characteristics of HPS participants by prior diabetes
The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure  Anna Gu, MD, PhD, Yu Yue, PhD, Joohae Kim, PharmD Candidate, Edgar.
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Fellström BC, et al. N Engl J Med 2009;360:1455-7
Charles J. Glueck, MD, Alan Brown, MD, Anne C. Goldberg, MD, James M
by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei
Description of studies for pooled analyses
Paul D. Thompson, MD, John Rubino, MD, Matthew J. Janik, MD, Diane E
Mika Kivimäki, Ritva Luukkonen, G. David Batty, Jane E
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
I. Introduction American Journal of Kidney Diseases
Coronary artery bypass grafting in diabetics: A growing health care cost crisis  Sajjad Raza, MD, Joseph F. Sabik, MD, Ponnuthurai Ainkaran, MS, Eugene.
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis  Moritz C. Wyler von Ballmoos, MD, MPH, Bernhard.
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia  Martine Paquette, MSc, Sophie.
Volume 73, Issue 8, Pages (April 2008)
Characteristics of included studies
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective  Matthew Baumgart, Heather M. Snyder,
The ACCORD Study Group. NEJM 2010; Epub March 14
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
III. Treating dyslipidemias
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:
Increased risk for dementia both before and after stroke: A population-based study in women followed over 44 years  Xinxin Guo, Svante Östling, Silke.
International Journal of Cardiology
Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients  Peter P. Toth, MD, PhD, Sephy Philip,
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study  Zhi Yu, Casey M. Rebholz, Eugenia.
Presentation transcript:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial  Anna Rosenberg, Tiia Ngandu, Minna Rusanen, Riitta Antikainen, Lars Bäckman, Satu Havulinna, Tuomo Hänninen, Tiina Laatikainen, Jenni Lehtisalo, Esko Levälahti, Jaana Lindström, Teemu Paajanen, Markku Peltonen, Hilkka Soininen, Anna Stigsdotter-Neely, Timo Strandberg, Jaakko Tuomilehto, Alina Solomon, Miia Kivipelto  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  DOI: 10.1016/j.jalz.2017.09.006 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Influence of sociodemographic factors, socioeconomic status, cognitive performance, and cardiovascular factors on intervention effects on the primary cognitive outcome (change in NTB total score). ∗P values are shown for interactions where baseline characteristics are continuous variables (except for sex, household income, and presence of cardiovascular comorbidity). Mixed-model repeated-measures analyses were used to investigate whether the baseline characteristics of the participants influenced intervention effects on cognitive performance (group × time × characteristic interactions). Nonsignificant P values for interaction (P > .05) indicate that the intervention effects on cognition do not vary by baseline characteristics. Characteristics were either dichotomous (sex, presence of cardiovascular comorbidity, and annual household income that was dichotomized based on median value) or continuous variables (age, education, MMSE, cardiovascular risk factors, and overall cardiovascular risk). To determine estimates for the difference between intervention and control groups per year within each subgroup, the continuous variables were dichotomized based on median values and mixed-models repeated-measures analyses were performed (group × time × dichotomous variable). A positive value of the estimate for the difference between intervention and control groups indicates that the effect is in favor of the intervention group. Data are based on all participants with at least one postbaseline measurement (mITT population). Overall cardiovascular risk is based on the FINRISK score and represents the risk of developing CVD compared to a person with the same age and sex but low risk. Presence of cardiovascular comorbidity is defined as having at least one of the following: history of stroke, history of myocardial infarction, or diabetes. Abbreviations: CI, confidence interval; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; mITT, modified intention-to-treat; MMSE, Mini–Mental State Examination; NTB, Neuropsychological Test Battery. Alzheimer's & Dementia: The Journal of the Alzheimer's Association DOI: (10.1016/j.jalz.2017.09.006) Copyright © 2017 The Authors Terms and Conditions